Publication: Dyslipidemia in an HIV-Positive Antiretroviral Treatment-Naive Population in Dar es Salaam, Tanzania
Open/View Files
Date
2011
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Ovid Technologies (Wolters Kluwer Health)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Armstrong, Catharina, Enju Liu, James Okuma, Donna Spiegelman, Chalamilla Guerino, Marina Njelekela, Steve Grinspoon, Wafaie Fawzi, and Claudia Hawkins. 2011. “Dyslipidemia in an HIV-Positive Antiretroviral Treatment-Naive Population in Dar Es Salaam, Tanzania.” JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (2) (June): 141–145. doi:10.1097/qai.0b013e318219a3d1.
Research Data
Abstract
Limited data are available on dyslipidemia in HIV-infected patients in resource-limited settings (RLS). We performed a cross-sectional analysis in ART-naïve, non-fasting HIV-infected patients in Tanzania between November 2004-June 2008. Robust linear regression modeling was performed. Lipid parameters were assessed in 12,513 patients (65% women; median (IQR) age, 36 (30–42) years; CD4 count, 143 (51–290) cells/mm3). Low HDL was prevalent in 67% and increased TG in 28%. High triglyceride and low HDL levels were associated with low CD4 counts (P<0.001). In this ART-naïve Tanzanian population, dyslipidemia was highly prevalent and associated with advanced disease. The impact of ART on these changes requires further exploration.
Description
Other Available Sources
Keywords
HIV positive, ART-naïve, Dyslipidemia, Tanzania, Cardiovascular disease
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service